CO7091173A2 - Sildenafil orodispersible tablet and method to prepare it - Google Patents

Sildenafil orodispersible tablet and method to prepare it

Info

Publication number
CO7091173A2
CO7091173A2 CO14122562A CO14122562A CO7091173A2 CO 7091173 A2 CO7091173 A2 CO 7091173A2 CO 14122562 A CO14122562 A CO 14122562A CO 14122562 A CO14122562 A CO 14122562A CO 7091173 A2 CO7091173 A2 CO 7091173A2
Authority
CO
Colombia
Prior art keywords
sildenafil
prepare
orodispersible tablet
orodispersible
tablet
Prior art date
Application number
CO14122562A
Other languages
Spanish (es)
Inventor
Hinojosa Raul Arturo Moreno
Garcia Leonardo Martinez
Flores Oliver Daniel Walls
Original Assignee
Liomont S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48573651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO7091173(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liomont S A De C V Lab filed Critical Liomont S A De C V Lab
Publication of CO7091173A2 publication Critical patent/CO7091173A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Abstract

La presente invención se refiere a una tableta orodispersable que comprende el agente activo sildenafil, uno o más diluyentes; uno o más desintegrantes; uno o más aglutinantes, y opcionalmente, uno o más aditivitos farmacéuticamente aceptables, y al procedimiento para preparar la misma.The present invention relates to an orodispersible tablet comprising the active agent sildenafil, one or more diluents; one or more disintegrants; one or more binders, and optionally, one or more pharmaceutically acceptable additives, and the procedure for preparing it.

CO14122562A 2011-12-08 2014-06-06 Sildenafil orodispersible tablet and method to prepare it CO7091173A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011013159A MX366768B (en) 2011-12-08 2011-12-08 Orodispersible sildenafil tablet and preparation method thereof.

Publications (1)

Publication Number Publication Date
CO7091173A2 true CO7091173A2 (en) 2014-10-21

Family

ID=48573651

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14122562A CO7091173A2 (en) 2011-12-08 2014-06-06 Sildenafil orodispersible tablet and method to prepare it

Country Status (5)

Country Link
CL (1) CL2014001487A1 (en)
CO (1) CO7091173A2 (en)
GT (1) GT201400108A (en)
MX (1) MX366768B (en)
WO (1) WO2013084191A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104546779A (en) * 2013-10-14 2015-04-29 深圳海王药业有限公司 Sildenafil citrate tablet with high medicine loading and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199900061A (en) * 1998-05-15 2000-10-14 Pfizer PHARMACEUTICAL FORMULATIONS.
CA2346350C (en) * 1998-10-05 2008-01-08 Eisai Co., Ltd. Intraoral quickly disintegrating tablets
WO2011030351A2 (en) * 2009-09-03 2011-03-17 Rubicon Research Private Limited Taste - masked pharmaceutical compositions

Also Published As

Publication number Publication date
MX2011013159A (en) 2013-06-14
WO2013084191A9 (en) 2013-08-15
CL2014001487A1 (en) 2015-02-13
WO2013084191A1 (en) 2013-06-13
MX366768B (en) 2019-07-17
GT201400108A (en) 2016-04-15

Similar Documents

Publication Publication Date Title
TW201144301A (en) Processes for preparing linezolid
MX2019002979A (en) Antibody formulations.
EA201590139A1 (en) SYRINGE
PT3172964T (en) Parasiticidal compositions comprising an isoxazoline active agent, method and uses thereof
BR112015002541A2 (en) compound, pharmaceutical composition, use of a compound, and method for treating hcv in a patient.
MX364229B (en) COMPOSITIONS and METHODS FOR TREATING CARDIOVASCULAR DISEASES.
ECSP15011603A (en) FISH IMMERSION VACCINE SUBUNITIES
BR112013031493A2 (en) compound, pharmaceutical composition, use of a compound, combination of a compound, device and process for preparing a compound.
BR112015003259A2 (en) compound, pharmaceutical composition, and vaccine composition.
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
AR093645A1 (en) A STABILIZED FORMULATION OF PEMETREXED
EP3068442A4 (en) Bionanofluid for use as a contrast, imaging, disinfecting and/or therapeutic agent
AR088099A1 (en) ANTICASPA COMPOSITION
BR112014025041B8 (en) PHARMACEUTICAL COMPOSITION
PH12016501841A1 (en) Immunosuppressant formulation
IN2013MU00711A (en)
CO2017007316A2 (en) Pharmaceutical formulation
IN2013MU01985A (en)
MX2014008390A (en) Romidepsin formulations and uses thereof.
MY162688A (en) Oral care compositions
WO2014145314A3 (en) Methods and compositions for gamma-glutamyl cycle modulation
BR112015002546A2 (en) braided puller, and cutting body for braided puller.
CY1118277T1 (en) STABLE PHARMACEUTICAL FORM PEXIGANANIS
CO7091173A2 (en) Sildenafil orodispersible tablet and method to prepare it
GB2543709A (en) Pharmaceutical agent